Beta Drugs (NSE:BETA) Short Percentage of Float


NSE:BETA Beta Drugs Ltd NSE:BETA
82 GF Score
Price ₹2,163.10
GF Value ₹1,960.95
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Beta Drugs Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:BETA vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Short Percentage of Float falls into.


NSE:BETA
82GF Score
Beta Drugs Ltd NSE:BETA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beta Drugs (NSE:BETA) Overvalued in 2026?

Based on GuruFocus' analysis, Beta Drugs stock appears to be overvalued. The current stock price of ₹2,163.10 is trading 10.3% above its estimated GF Value™ of ₹1,960.95. GuruFocus considers Beta Drugs to be Fairly Valued.

Key valuation signals for NSE:BETA:

  • Short Percentage of Float:
  • GF Value™: ₹1,960.95 vs. price of ₹2,163.10 (10.3% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the NSE:BETA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beta Drugs Business Description

Address SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
82GF Score

Get the complete analysis for NSE:BETA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,163.10
Price
₹1,960.95
GF Value